144 related articles for article (PubMed ID: 11790290)
1. Progress in secondary prevention of stroke with PROGRESS. The perindopril protection against recurrent stroke study.
Schiffrin EL
Curr Hypertens Rep; 2002 Feb; 4(1):39-40. PubMed ID: 11790290
[No Abstract] [Full Text] [Related]
2. PROGRESS - Perindopril Protection Against Recurrent Stroke Study: characteristics of the study population at baseline. Progress Management Committee.
J Hypertens; 1999 Nov; 17(11):1647-55. PubMed ID: 10608480
[TBL] [Abstract][Full Text] [Related]
3. Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack.
Arima H; Hart RG; Colman S; Chalmers J; Anderson C; Rodgers A; Woodward M; MacMahon S; Neal B;
Stroke; 2005 Oct; 36(10):2164-9. PubMed ID: 16141420
[TBL] [Abstract][Full Text] [Related]
4. Trials on blood pressure-lowering and secondary stroke prevention.
Chalmers J
Am J Cardiol; 2003 May; 91(10A):3G-8G. PubMed ID: 12781902
[TBL] [Abstract][Full Text] [Related]
5. Progress in reducing the burden of stroke.
Chalmers J; Chapman N
Clin Exp Pharmacol Physiol; 2001 Dec; 28(12):1091-5. PubMed ID: 11903323
[TBL] [Abstract][Full Text] [Related]
6. [Clinical study of the month. Secondary prevention of cerebrovascular accident with perindopril: the PROGRESS study].
Scheen AJ
Rev Med Liege; 2001 Nov; 56(11):792-5. PubMed ID: 11789395
[TBL] [Abstract][Full Text] [Related]
7. Stroke secondary prevention and blood pressure reduction: an observational study of the use of PROGRESS therapy.
Bugnicourt JM; Chillon JM; Canaple S; Lamy C; Godefroy O
Fundam Clin Pharmacol; 2008 Apr; 22(2):217-22. PubMed ID: 18353116
[TBL] [Abstract][Full Text] [Related]
8. Blood pressure-lowering for secondary prevention of stroke: ACE inhibition is not the key.
Bath P
Stroke; 2003 May; 34(5):1334-5. PubMed ID: 12702833
[No Abstract] [Full Text] [Related]
9. Perindopril pROtection aGainst REcurrent Stroke Study (PROGRESS): interpretation and implementation.
Chalmers J; MacMahon S
J Hypertens Suppl; 2003 Jun; 21(5):S9-14. PubMed ID: 12953850
[TBL] [Abstract][Full Text] [Related]
10. The PROGRESS trial: questions about the effectiveness of angiotensin converting enzyme inhibitors. Perindopril pROtection aGainst REcurrent Stroke Study.
Psaty BM; Weiss NS; Furberg CD
Am J Hypertens; 2002 May; 15(5):472-4. PubMed ID: 12022252
[No Abstract] [Full Text] [Related]
11. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.
PROGRESS Collaborative Group
Lancet; 2001 Sep; 358(9287):1033-41. PubMed ID: 11589932
[TBL] [Abstract][Full Text] [Related]
12. Incidence of recurrent stroke in primary care during preventive treatment based on perindopril with or without indapamide.
Padma MV; Kaul S
Neurol India; 2007; 55(2):141-4. PubMed ID: 17558118
[TBL] [Abstract][Full Text] [Related]
13. Effects of a perindopril-based blood pressure-lowering regimen on disability and dependency in 6105 patients with cerebrovascular disease: a randomized controlled trial.
Fransen M; Anderson C; Chalmers J; Chapman N; Davis S; MacMahon S; Neal B; Sega R; Terent A; Tzourio C; Woodward M;
Stroke; 2003 Oct; 34(10):2333-8. PubMed ID: 12958329
[TBL] [Abstract][Full Text] [Related]
14. Role of perindopril in the prevention of stroke.
Papadopoulos DP; Votteas V
Recent Pat Cardiovasc Drug Discov; 2006 Nov; 1(3):283-9. PubMed ID: 18221093
[TBL] [Abstract][Full Text] [Related]
15. Blood-pressure lowering for the secondary prevention of stroke.
Staessen JA; Wang J
Lancet; 2001 Sep; 358(9287):1026-7. PubMed ID: 11589927
[No Abstract] [Full Text] [Related]
16. Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial.
Chapman N; Huxley R; Anderson C; Bousser MG; Chalmers J; Colman S; Davis S; Donnan G; MacMahon S; Neal B; Warlow C; Woodward M;
Stroke; 2004 Jan; 35(1):116-21. PubMed ID: 14671247
[TBL] [Abstract][Full Text] [Related]
17. Lower blood pressure and risk of recurrent stroke in patients with chronic kidney disease: PROGRESS trial.
Ninomiya T; Perkovic V; Gallagher M; Jardine M; Cass A; Arima H; Anderson C; Neal B; Woodward M; Omae T; MacMahon S; Chalmers J;
Kidney Int; 2008 Apr; 73(8):963-70. PubMed ID: 18272959
[TBL] [Abstract][Full Text] [Related]
18. Blood pressure lowering in PROGRESS (Perindopril Protection Against Recurrent Stroke Study) and white matter hyperintensities: should this progress matter to patients?
Schiffrin EL
Circulation; 2005 Sep; 112(11):1525-6. PubMed ID: 16157782
[No Abstract] [Full Text] [Related]
19. Angiotensin-converting enzyme inhibition in cardiovascular disease: evidence with perindopril.
Ferrari R
Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):15-29. PubMed ID: 15723572
[TBL] [Abstract][Full Text] [Related]
20. Clinical implications of PROGRESS: questions and answers.
Chalmers J; Adams HP; Donnan GA; Fox K; MacMahon S; Mancia G; Tzourio C
J Hypertens Suppl; 2003 Jun; 21(5):S21-4. PubMed ID: 12953852
[No Abstract] [Full Text] [Related]
[Next] [New Search]
